Filing Details
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) filed a Form 8-K with the Securities and Exchange Commission on November 09, 2026, disclosing a material event.
8k filedNASDAQ:WHWK
Whitehawk Therapeutics, Inc. (WHWK) Reports Material Event to SEC
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) filed a Form 8-K with the Securities and Exchange Commission on November 09, 2026, disclosing a material event.
At publication ·
What changed
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Whitehawk Therapeutics filed a Form 8-K on November 9, 2026, disclosing a material event to shareholders.
- The stock trades at $3.13 with a market capitalization of $117.8 million.
- Form 8-K filings report events such as leadership changes, material agreements, acquisitions, or asset sales between regular reports.
Market Context
Whitehawk Therapeutics, Inc.'s stock currently trades at $3.13 with a market capitalization of $117.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Whitehawk Therapeutics, Inc.'s stock.
All SEC filings for Whitehawk Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View WHWK Stock Page
Frequently Asked Questions
Where can I read WHWK's SEC filings?
Browse all filings on our WHWK SEC filings page.
What types of SEC filings does Whitehawk Therapeutics, Inc. file?
Public companies like Whitehawk Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.